MR fusion guided prostate biopsy: A new way to detect prostate cancer

the ONA take:

A new diagnostic technique, MR fusion guided prostate biopsy, may hold promise for greater prostate cancer detection. Traditional biopsy measures target the lower region of the prostate, missing nearly a third of existing cancers. In this phase 3 study, researchers used a new prostate fusion biopsy method that combines ultrasound and MR imaging to examine 105 men. Prostate cancer was detected in 62.9 percent of the men tested in this trial, compared to the approximately 30 to 40 percent detection rate reported in previous investigations utilizing a standard 12-core ultrasound biopsy.

MR fusion guided prostate biopsy: A new way to detect prostate cancer
MR fusion guided prostate biopsy: A new way to detect prostate cancer

Technology to perform prostate biopsies has been relatively unchanged since the 1980′s. Traditional techniques only sample the lower portion of the prostate, yet nearly 30 percent of cancers are located outside this zone.

For men with ongoing concern for cancer—persistently elevated prostate specific antigen (PSA) (a blood marker for prostate cancer) and repeatedly negative or normal biopsies—a new technique, MR fusion guided prostate biopsy, may hold promise.

READ FULL ARTICLE From Forbes
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs